The urgent need for improved support for SEND pupils

Pupils with special educational needs and disabilities (SEND) are continuing to fall behind their peers with the gap widening despite the introduction of SEND legislation.

Specialty Pharmacy Drives 3.8% Increase in Drug Prices

What You Should Know: – Vizient, Inc., a leading healthcare performance improvement company, has released its latest Pharmacy Market Outlook, projecting a 3.8% growth in

January 31, 2024

Vita 34 continues to show increasing revenue, improved profitability and stronger cash generation in the third quarter of 2024 – Biotech Investments

EQS-News: Vita 34 AG / Key word(s): 9 Month figures Vita 34 continues to show increasing revenue, improved profitability and stronger cash generation in the

November 23, 2024

CRISPR-based Casgevy is made accessible in England following NICE guidance – Pharmaceutical Technology

The CRISPR/Cas9 gene-editing therapy Casgevy offers a one-time curative option for beta-thalassemia patients. Image: Shutterstock/Perception7 Following positive guidance issued by the National Institute for Health

August 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.